中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 合肥物质科学研究院
  3. 中国科学院合肥物质科学研究院
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors

文献类型：期刊论文

作者Xu, Xiaoling7,8; Wang, Ding6; Chen, Wei7; Li, Na6,7; Suwinski, Rafal5; Rossi, Antonio4; Rosell, Rafael3; Zhong, Jianxiang2; Fan, Yun1,6,7
刊名TRANSLATIONAL LUNG CANCER RESEARCH
出版日期2021-12-14
关键词Immune checkpoint inhibitor (ICI) non-small cell lung cancer (NSCLC) peripheral blood lymphocyte subsets
ISSN号2218-6751
DOI10.21037/tlcr-21-899
通讯作者Zhong, Jianxiang(jzhong85109@hotmail.com) ; Fan, Yun(fanyun1218@163.com)
英文摘要Background: The primary aim of this study was to investigate the prognostic value of peripheral blood lymphocyte subsets in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs). Methods: From 2018 to 2019, 82 patients diagnosed with stage IIIB-IV NSCLC at Zhejiang Cancer Hospital were recruited for this study. Peripheral blood lymphocyte subsets of NSCLC patients were analyzed using flow cytometry before and after ICI treatment. The relationship between the percentage of peripheral blood lymphocyte subsets, clinicopathological features, progression-free survival (PFS), and overall survival (OS) was identified by correlation heat map, Kaplan-Meier curve, log-rank test, and Cox regression analysis. Results: The CD4/CD8 ratio and the percentage of B cells was decreased after ICI treatment. Furthermore, the percentage of CD3(+) T cells, natural killer (NK) cells, and natural killer T (NKT) cells before ICI treatment was associated with brain metastases, the proportion of CD3(+)CD4(+) T cells before ICI treatment was related to epidermal growth factor receptor (EGFR) status, the CD4/CD8 ratio before ICI treatment was correlated to pathology, the ratio of B cells before ICI treatment was related to therapeutic regimen, and the percentage of NKT cells before ICI treatment was associated with use of radiotherapy. Furthermore, univariate survival analysis revealed that low percentage of B cells forecasted a poor OS for NSCLC patients with ICI treatment. In addition, the nomogram developed by percentages of peripheral blood lymphocyte subsets could determine survival probability and survival time of NSCLC patients with immunotherapy. Conclusions: ICI treatment induced changes in the percentage of peripheral blood lymphocyte subsets, which had prognostic value for brain metastases, radiotherapy, EGFR status, pathology, and therapeutic regimen, along with prognostic value, for NSCLC patients treated with ICIs.
WOS关键词IMMUNOTHERAPY ; NSCLC
资助项目National Natural Science Foundation of China[81802995] ; Zhejiang Province Public Welfare Funds[LGF19H280004]
WOS研究方向Oncology ; Respiratory System
语种英语
WOS记录号WOS:000734092800001
出版者AME PUBL CO
资助机构National Natural Science Foundation of China ; Zhejiang Province Public Welfare Funds
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/127187]  
专题中国科学院合肥物质科学研究院
通讯作者Zhong, Jianxiang; Fan, Yun
作者单位1.Univ Chinese Acad Sci, Zhejiang Key Lab Diag & Treatment Technol Thorac, Inst Canc Res & Basic Med Sci, Canc Hosp,Chinese Acad Sci,Zhejiang Canc Hosp, Hangzhou, Peoples R China
2.Southeast Univ, Sch Life Sci & Technol, 2 Sipailou, Nanjing, Peoples R China
3.Germans Trias & Pujol Hlth Sci Inst & Hosp IGTP, Canc Biol & Precis Med Unit, Barcelona, Spain
4.IQVIA, Oncol Ctr Excellence, Therapeut Sci & Strategy Unit, Milan, Italy
5.Maria Sklodowska Curie Natl Res Inst Oncol, Radiotherapy & Chemotherapy Clin & Teaching Hosp, Gliwice, Poland
6.Zhejiang Chinese Med Univ, Clin Med Coll 2, 548 Binwen Rd, Hangzhou 310053, Peoples R China
7.Chinese Acad Sci, Inst Canc & Basic Med IBMC, 1 East Banshan Rd, Hangzhou, Peoples R China
8.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Key Lab Head & Neck Canc Translat Res Zhejiang Pr, Canc Hosp, 1 East Banshan Rd, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714		 Xu, Xiaoling,Wang, Ding,Chen, Wei,et al. A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors[J]. TRANSLATIONAL LUNG CANCER RESEARCH,2021.
APA Xu, Xiaoling.,Wang, Ding.,Chen, Wei.,Li, Na.,Suwinski, Rafal.,...&Fan, Yun.(2021).A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors.TRANSLATIONAL LUNG CANCER RESEARCH.
MLA Xu, Xiaoling,et al."A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors".TRANSLATIONAL LUNG CANCER RESEARCH (2021).

入库方式： OAI收割

来源：合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。